MISSION, Kan., April 30, 2018 -- (Family Features) Alzheimer’s disease is the sixth leading cause of death overall in the United States and affects more than 5 million Americans. According to experts, this number could triple to nearly 16 million people by 2050. A momentous scientific study focused on early detection of Alzheimer’s disease, and tracking it over time, seeks healthy volunteers without memory problems, as well as people who have mild memory problems and those who have been diagnosed with mild dementia due to Alzheimer’s disease.
|
|||||
The prestigious Alzheimer’s Disease Neuroimaging Initiative – or ADNI – funded by the National Institutes of Health, is one of the largest and longest running Alzheimer’s disease trials in history. Now in the third phase of trials, researchers are studying how quickly things like reasoning and the ability to perform certain functions change in the aging brain. Researchers need to better understand the disease progression in order to speed the pace of discovery in the race to prevent, treat and cure Alzheimer’s disease.
“It is extremely important that more people get involved in the fight against Alzheimer’s disease, which affects nearly all of us in some way,” said Michael Weiner, MD, principal investigator of the study. “We need to know how Alzheimer’s disease progresses in order to discover new treatments that could significantly improve the way we treat it in the future.”
The study uses state-of-the-art imaging to monitor brain levels of two proteins called tau and amyloid, both of which are significant indicators of Alzheimer’s disease. Researchers track cognitive function through computer tests at home and in a doctor’s office, which includes measuring changes in one’s ability to handle money, a common warning sign of the disease.
“One of the biggest challenges researchers face is finding people to volunteer to take part in studies,” said Weiner. “We can beat Alzheimer’s, but we can’t do it without volunteers. We need help.”
The ADNI Study needs 800 people to enroll in sites across the United States and in Canada. Researchers are looking for people between the ages of 55 and 90 who have normal thinking and memory function, as well as those who have mild memory problems and those who have been diagnosed with mild dementia due to Alzheimer’s disease. No medication is involved.
Potential study volunteers can learn more by visiting www.ADNI3.org or by calling 1-888-2-ADNI-95 (1-888-223-6495).
Michael French
[email protected]
1-888-824-3337
editors.familyfeatures.com
About Family Features Editorial Syndicate
Established in 1974, Family Features is a leading provider of free food and lifestyle content for print and online publications. Our articles, photos, videos and web content solutions save you time, money and help create advertising opportunities. Registration is fast and free – with absolutely no obligation. Visit editors.familyfeatures.com for more information.
A photo accompanying this announcement is available at http://resource.globenewswire.com/Resource/Download/9fbc4729-166c-4135-90f2-796899ff0219


Chinese Chip Stocks Jump as Apple Reportedly Tests CXMT Memory Chips for China Devices
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion
BHP Faces Port Hedland Strike Threat as Iron Ore Export Risks Grow
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results
Fast Retailing Raises Full-Year Forecast After Uniqlo Owner Beats Q3 Profit Estimates
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth
Oil and LNG Tankers Turn Back as Strait of Hormuz Security Risks Escalate
Telenor to Buy Controlling Stake in Bahnhof in $630 Million Broadband Deal
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand
Apple Sues OpenAI, Former Employees Over Alleged Trade Secret Theft
SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO
Morgan Stanley Names Marks & Spencer Top European Retail Pick, Sees Strong Upside
OpenAI GPT-5.6 Set for Wider Release After U.S. Commerce Approval, Report Says
Netflix, Disney, YouTube Eye FIFA World Cup TV Rights in Multi-Billion Dollar Battle
Nvidia Invests $500M in Firmus Technologies Ahead of Planned ASX IPO 



